SUO 2022 Prostate Cancer

Viewing 1-10 of 10 articles

SUO 2022: Using Biomarkers and Somatic Testing to Guide Treatment Choice

SUO 2022: Geographic Variation in Utilization of Doublet Therapy for Metastatic Prostate Cancer

SUO 2022: External Validation of a Digital Pathology-Based AI Model Predicting Metastasis and Death in High and Very High Risk Men on NRG/RTOG 9902 Phase III Trial

SUO 2022: The Joseph A. Smith Jr. Mentorship Award Lecture

SUO 2022: Use of Exogenous Testosterone in The Setting Of Screening, Active Surveillance, and After Treatment of Localized Disease

SUO 2022: Bipolar Androgen Therapy in Advanced Prostate Cancer

SUO 2022: Diagnostic Performance and Safety of 18F-rhPSMA-7.3 PET in Patients with Newly Diagnosed Prostate Cancer: Results from a Phase 3, Prospective Multicenter Study (LIGHTHOUSE)

SUO 2022: Inequities In Cancer Screening, Treatment And Outcomes

SUO 2022: Theragnostics: The VISION Trial and Beyond

SUO 2022: Theranostics in High-Risk Localized Prostate Cancer